Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer

This study has been completed.
Sponsor:
Collaborator:
Xiansheng Pharmaceutical Company
Information provided by (Responsible Party):
Shen Lin, Peking University
ClinicalTrials.gov Identifier:
NCT00842491
First received: February 11, 2009
Last updated: May 17, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)